# The Thalion Initiative > The Thalion Initiative is a 501(c)(3) not-for-profit research organization dedicated to advancing fundamental aging biology to support the development of new therapeutic strategies. Founded in 2024 and headquartered in Boston, MA with a Canadian office in Ottawa, ON. EIN: 33-2228263. The Thalion Initiative applies a first-principles, systems-engineering approach to aging biology research. The organization integrates embryonic rejuvenation, comparative biology, synthetic biology, and advanced computational tools to address critical knowledge gaps in how organisms age. The initiative's core thesis is that aging is the primary risk factor for over 70% of chronic diseases contributing to all-cause mortality, and that understanding its fundamental mechanisms will unlock transformative therapeutic strategies. The research program is structured in three phases: Phase I (2025–2030) focuses on foundational research, tool development, and large-scale dataset generation. Phase II (2033–2038) targets translational applications and therapeutic interventions. Phase III (2035–2040) aims for clinical translation and commercialization. The scientific advisory board includes leading researchers across aging biology, comparative biology, synthetic biology, computational modeling, and biological tooling from institutions worldwide. ## About - [Home](https://thalion.global/): Main landing page presenting the case for rethinking the fundamental biology of aging, mission overview, key objectives, and phased research strategy. - [About Us](https://thalion.global/about): Organizational overview including vision, guiding principles (first-principles thinking, collaboration across disciplines, data-driven research, ethics and open science), and strategic goals. - [Our Team](https://thalion.global/team): Leadership team and scientific advisory board with bios. Leadership: Maria Marinova, Ph.D. (Scientific Director), Maximilian Unfried, Ph.D. (Scientific Director), Todd White (Managing Director). Advisory board spans comparative biology, synthetic biology, biological tooling, embryogenesis, computational modeling, and aging biology general. - [Contact](https://thalion.global/contact-us): Contact information. Email: info@thalion.global. US Head Office: Boston, MA. Canada Head Office: Ottawa, ON. ## The Challenge - [The Challenge](https://thalion.global/challenge): Detailed analysis of why biomedical innovation is stagnating, covering Eroom's Law (declining drug development productivity), high clinical trial failure rates, patent expirations, the decline of disruptive science, limited predictive models, and the case for aging biology as a unifying approach. Explains shared disease pathways, healthspan vs. lifespan, and the demographic and economic case for aging research. ## Research Approach - [Our Approach](https://thalion.global/approach): The Thalion first-principles methodology for aging biology research. Covers the need for improved predictability in biology, data generation priorities, tool development, the three-phase research roadmap, and interdisciplinary insights drawn from physics, chemistry, and biology applied to aging. ## Research Focus Areas - [Focus Areas Overview](https://thalion.global/focus-areas): Hub page listing all research programs with brief descriptions and links to detailed program pages. - [Embryonic Rejuvenation](https://thalion.global/programs/embryogenesis): Research into how embryos reset biological age and how germline cells protect future generations. Projects include dynamics, mechanisms, and applications of embryonic rejuvenation, and maintenance of reduced biological age in the germline. Key concepts: epigenetic changes, metabolic reprogramming, bioelectric signaling, multi-omic profiling, gastrulation, iPSCs. - [Comparative Biology](https://thalion.global/programs/comparative-biology): Studying longevity and disease resistance across species including bowhead whales (200+ year lifespan), naked mole rats (cancer resistance), elephants (cancer suppression via p53), and axolotls (regeneration). Goal: decode evolutionary strategies applicable to human health. - [Synthetic Biology](https://thalion.global/programs/synthetic-biology): Engineering biological functions to mitigate aging mechanisms. Developing synthetic biology tools for therapeutic applications in longevity. - [Advanced Tooling](https://thalion.global/programs/tooling-for-measurement): Developing new measurement and modeling technologies for aging research, including advanced metabolomics, proteomics, and epigenomics platforms. - [Computational Modelling](https://thalion.global/programs/computational-modelling): Simulating aging processes to enhance therapy prediction and accelerate longevity research. Includes development of predictive computational models for biological aging. ## Support - [Support Our Programs](https://thalion.global/support): Information on supporting the initiative through Donor Advised Funds (DAF), direct cash donations, gifts-in-kind (crypto, securities, real estate), bequests, and retirement plan proceeds. - [Patrons](https://thalion.global/patrons): Information about the patron program. ## Legal - [Privacy Policy](https://thalion.global/privacy-policy): Website privacy policy and data handling practices. ## Optional - [GuideStar Profile](https://www.guidestar.org/Profile/33-2228263): Candid/GuideStar nonprofit profile with Gold Seal transparency designation. - [Twitter/X](https://x.com/ttiscience): Official social media presence (@TTIScience).